|
||||||||||||||||||||||||||||||||||||||||||||||||
Table 3: Uncertainties estimated in each step of ECs analysis for each compound. Uncertainty associated with stock solution preparation at 1000 mg/L (u1), working solution preparation at 100 mg/L (u2) and sample treatment (u3) is 1.20, 0.59 and 1.45 %, respectively. |